INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
VM

Veness Adam M

SVP, General Counsel and Sec.CIK 0001778623

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 3
Max Insider Score28
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise
M$273K
15.0K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Dianthus Therapeutics, Inc. /DE/SVP, General Counsel and Sec. · Aug 11, 2026
13
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise
M
—
15.0K sh
Aug 13, 2026
Aug 14, 2026
traded Aug 13, 2026
+1d
SEC FORM 4

Evidence

2
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$69K
3,833 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC FORM 4

Evidence

28
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$356K
3,217 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC FORM 4

Evidence

25
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$68K
616 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC FORM 4

Evidence

3
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
3,833 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC FORM 4

Evidence

1
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$289K
16.2K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

27
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.78M
16.2K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

3
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
16.2K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence